EDGAR Filing Documents for 0001171843-23-000739

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001171843-23-000739

Filing Date

2023-02-07

Accepted

2023-02-07 08:01:51

Documents

Period of Report

2022-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	f6k_020723.htm	6-K	10936
2	EXHIBIT 99.1	exh_991.htm	EX-99.1	255521
3	EXHIBIT 99.2	exh_992.htm	EX-99.2	213624
4	EXHIBIT 99.3	exh_993.htm	EX-99.3	5914
5	EXHIBIT 99.4	exh_994.htm	EX-99.4	5882
6	EXHIBIT 99.5	exh_995.htm	EX-99.5	22293
7	GRAPHIC	logo.jpg	GRAPHIC	7288
8	GRAPHIC	abilityschema.jpg	GRAPHIC	143049
9	GRAPHIC	noevidence.jpg	GRAPHIC	50563
10	GRAPHIC	pharmacodoses.jpg	GRAPHIC	46546
11	GRAPHIC	lympexpan.jpg	GRAPHIC	66278
12	GRAPHIC	stimulated.jpg	GRAPHIC	41797
13	GRAPHIC	treat.jpg	GRAPHIC	82298
14	GRAPHIC	mdna223over.jpg	GRAPHIC	61197
15	GRAPHIC	mdna223model.jpg	GRAPHIC	61144
	Complete submission text file	0001171843-23-000739.txt		1287880

Mailing Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2

Business Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2 416 648-5555

Medicenna Therapeutics Corp. (Filer) CIK: 0001807983 (see all company filings)